Create a homepage for external communication
Collect case studies of how good looks like
Publish manuscripts in journals and communicate via other channels about:
The role statisticians do and can play in medical affairs and their imapct.
Innovative designs in medical affairs.
Use of registries in medical affairs.
Use of historical data in medical affairs.
Implementation of pragmatic studies in medical affairs.
Organize workshops and conference sessions around the topics mentioned above.
Public relation activities to show how statisticians and adata can help make better decisions.
Collaboration with non-statistical associations (e.g. medical) working in the field to improve the role of statistics.
Develop best practices for statisticians to be successful and efficent (evidence dissemination and resources, planning and strategic thinking.)
Jenny Devenport (Roche) (Co-Chair)
Yulia Dyachkova (Merck) (Co-Chair)
Alexander Schacht
Anny Stari
Aontonia Ridolfi
Bob Shaw
Cornelia Dunger-Baldauf, Cornelia
Daniel Saure
Gbenga Kazeem
Giacomo Mordenti
Knut Richert
Frank Langer
Lada Mitchell
Lucy Wright
Martin Blogg
Nathalie Barbier
Pierre Mancini
Stefan Franzén
Thomas Kuenzel
Véronique Robert
Slides from PSI Annual Conference 2022
Poster from EFSPI Regulatory Conference 2022
Contact Jenny Devenport or Yulia Dyachkova
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
The webinar will show how the estimand framework was applied in a Phase 3 trial in Alzheimer's disease.
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This webinar will discuss opportunities in applying causal inference methodology during the analysis of RCT data.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
